BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6310891)

  • 1. [Intratumor chemotherapy of patients with cancer of the ovaries].
    Vinokurov VL; Mitrokhina MV
    Vopr Onkol; 1983; 29(8):58-61. PubMed ID: 6310891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immediate results of sarcolysine therapy of patients with malignant tumors of the ovaries].
    Semenovskiĭ AV
    Vopr Onkol; 1983; 29(3):54-7. PubMed ID: 6836988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
    Dzhilavian GA; Vinokurov VL
    Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy for ovarian cancer].
    Lindell A
    Lakartidningen; 1968 Mar; 65(11):1120-2. PubMed ID: 5743130
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined chemotherapy of ovarian cancer with special reference to carboquone].
    Sugimori H; Kidera Y; Matsuyama T
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):66-71. PubMed ID: 6307172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytostatic treatment of pseudomyxoma peritonei].
    Schneider T; Lotze W
    Zentralbl Gynakol; 1985; 107(24):1525-7. PubMed ID: 3004068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L; Lepage E; Breau JL; Aguilera J
    Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of chemotherapy on the prognosis of ovarian cancer].
    Sugawa T; Umesaki N; Yajima A; Satoh S; Terashima Y; Ochiai K; Tomoda Y; Kanoh T; Noda K; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1135-41. PubMed ID: 1333504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and immunodiagnosis of advanced ovarian adenocarcinoma: a preliminary report.
    Piver MS; Barlow JJ; Bhattacharya M
    Cancer Treat Rep; 1979 Feb; 63(2):265-7. PubMed ID: 376133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methods of optimizing and objective criteria for evaluating the efficacy of chemo-surgical treatment of malignant epithelial tumors of the ovaries].
    Nechaeva ID; Vinokurov VL; Iurkova LE; Kotova DG; Aĭnbinder NM; Livshits MA; Zel'dovich DR; Mitrokhina MV
    Vopr Onkol; 1990; 36(8):992-5. PubMed ID: 2171227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of ovarian cancer. New approaches to treatment.
    Smith JP; Rutledge F; Wharton JT
    Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
    Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in the treatment of cancer of the ovary.
    Smith JP; Rutledge F
    Am J Obstet Gynecol; 1970 Jul; 107(5):691-703. PubMed ID: 4316665
    [No Abstract]   [Full Text] [Related]  

  • 15. [1st report on programmed chemotherapy of ovarian carcinoma].
    Frank S; Richter K; Ehrhart H; Penning W; Meister P; Schmidt D; Götz A
    Fortschr Med; 1975 Oct; 93(28):1309-12. PubMed ID: 1228086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose thiotepa in ovarian cancer.
    Shetty PA; Kurkure PA; Pai VR; Gohokar D; Pai S; Shinde SR; D'Souza LJ; Sampat MB
    Indian J Cancer; 1985 Mar; 22(1):33-7. PubMed ID: 3939232
    [No Abstract]   [Full Text] [Related]  

  • 17. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment.
    Sugarbaker PH; Landy D; Pascal R
    Prog Clin Biol Res; 1990; 354B():141-70. PubMed ID: 2236162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of bleomycin in patients with advanced epithelial ovarian cancer.
    Blackledge G; Lawton F; Buckley H; Crowther D
    Cancer Treat Rep; 1984 Mar; 68(3):549-50. PubMed ID: 6200221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.